Skip to Main Content

Paper Details

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women.
BMJ Open
21
2022
Author NameAffiliation
William J MossOak Crest Institute of Science
  • 1 - 1

Datasets

Release 1.2